Amrize (AMRZ) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
18 Feb, 2026Executive summary
Revenues grew 0.9% to $11.8 billion in 2025, with adjusted EBITDA of $3.0 billion and net income of $1.18 billion, driven by infrastructure and commercial demand.
Free cash flow reached $1.5 billion (49% conversion), and net leverage ratio improved to 1.1x.
Completed a successful spin-off and announced the acquisition of PB Materials to expand aggregates in West Texas.
Board approved a $1 billion share repurchase and proposed $0.44 per share special and annual dividends.
CapEx investments increased 23% to $788 million in 2025, with plans to rise to $900 million in 2026.
Financial highlights
Q4 2025 building materials revenues grew 3.9% to $2.16 billion, with adjusted EBITDA up 5.9% to $705 million.
Building envelope Q4 revenues declined 11.8% to $678 million, with adjusted EBITDA down 23.5% to $130 million.
Full-year adjusted EBITDA margin was 25.5%, and net debt at year-end was $3.35 billion.
Free cash flow for 2025 was $1.5 billion, with a 49% cash conversion rate.
Cement and aggregates volumes increased in Q4, with aggregates pricing up 3.8% year-over-year.
Outlook and guidance
2026 guidance: revenues of $12.29–$12.52 billion (+4–6%) and adjusted EBITDA of $3.25–$3.34 billion (+8–11%), including PB Materials acquisition.
Cement pricing expected to rise low single digits; aggregates mid-single digits; positive volume growth in both.
Building envelope: low single-digit commercial roofing volume growth, flat residential volumes with improvement in H2.
Aspire/ASPIRE program targets 70 basis points margin expansion in 2026 and $250 million synergies by 2028.
Net leverage ratio expected to remain below 1.5x.
Latest events from Amrize
- 2026 AGM proxy covers key votes, governance, compensation, and ESG priorities.AMRZ
Proxy Filing12 Mar 2026 - AGM to address board elections, executive pay, distributions, and non-financial reporting.AMRZ
Proxy Filing12 Mar 2026 - 2026 AGM proxy covers financials, compensation, board elections, and strong governance initiatives.AMRZ
Proxy Filing27 Feb 2026 - Stable Q2 2025 results and synergy program support strong outlook and long-term growth.AMRZ
Q2 202523 Nov 2025 - Q3 revenue up 6.6% to $3,675M, net income $543M, 2025 guidance raised to $12.0B.AMRZ
Q3 202529 Oct 2025